Quintiles, Inc. Consolidates EU Business with Headquarters in UK
Published: Oct 12, 2011
Lord Howe, Parliamentary Under-Secretary of State for Health commented: "Having Quintiles open their European headquarters in Reading is excellent news. Their decision shows that the UK is an attractive environment for international pharmaceutical companies to invest in.
“The Government is committed to promoting the development of new, innovative treatments for NHS patients and I look forward to seeing the results of the exciting work that Quintiles will carry out at Reading."
In an opening ceremony, Quintiles founder, Chairman and Chief Executive Officer Dennis Gillings, CBE, stressed the continued importance of Europe, particularly the UK, in the global market, and Quintiles’ investment in innovation and quality across the spectrum of drug development and commercialization.
Gillings said: “I am proud to extend our strategic commitment to Europe, Middle East and Africa with this regional headquarters investment. With such a wealth of scientific, medical and commercial expertise in the UK, the move has encouraged more cross-discipline collaboration to better serve Quintiles’ customers and power them forward in the fast-morphing world of biopharma.”
This further investment by Quintiles follows the opening of its state of the art laboratory and office facility in Edinburgh, Scotland in 2009 and the expansion of its Phase I facility in London, completed in March 2010. In June 2011 Quintiles opened a new office in Madrid, Spain and in July 2011 Quintiles’ first prime site facility, Queen Mary, University of London, officially opened a clinical research facility.
With the opening of its new European Headquarters, more than 500 staff-members have relocated from three separate offices into a single, state-of-the-art facility, located within 30 minutes of Heathrow Airport at Green Park, Reading just off the M4 motorway.
Quintiles employs more than 2,000 people in the United Kingdom and over 9,000 across Europe, Middle East and Africa. In 2011, the company was named as one of the best workplaces in several countries by the Great Place to Work Institute and qualified as one of the 25 best workplaces in Europe.
Quintiles is the only fully integrated bio pharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries works with an unwavering commitment to patients, safety and ethics. Quintiles helps bio pharmaceutical companies navigate risk and seize opportunities in an environment where change is constant. For more information, please visit www.quintiles.com.
Greg Connors, Investor Relations
Office: +1 919 998 2000
Laura Wilson, Media Relations
Office: +44 118 450 8392